Quantum BioPharma Ltd.
NASDAQ: QNTM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zeeshan Saeed
- Employees
- 17
- Headquarters
- Toronto, Canada
- IPO year
- 2018
- Market cap
- $17.6M
- Website
- https://www.quantumbiopharma.com
Loading QNTM…
Loading profile data…Frequently asked questions about QNTM
What does Quantum BioPharma Ltd. (QNTM) do?
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a rang...
Where does QNTM trade?
Quantum BioPharma Ltd. (QNTM) trades on the NASDAQ Global Market.
What sector is QNTM in?
Quantum BioPharma Ltd. (QNTM) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Quantum BioPharma Ltd.?
Zeeshan Saeed is the chief executive officer of Quantum BioPharma Ltd. (QNTM).
Where is Quantum BioPharma Ltd. headquartered?
Quantum BioPharma Ltd. is headquartered in Canada.
Does QNTM pay a dividend?
Quantum BioPharma Ltd. (QNTM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QNTM go public?
Quantum BioPharma Ltd. (QNTM) completed its initial public offering in 2018.